EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma

BACKGROUND: Meningiomas are the most common primary brain tumor in adults, and somatic loss of the neurofibromatosis 2 (NF2) tumor suppressor gene is a frequent genetic event. There is no effective treatment for tumors that recur or continue to grow despite surgery and/or radiation. Therefore, targe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Angus, Steven P, Oblinger, Janet L, Stuhlmiller, Timothy J, DeSouza, Patrick A, Beauchamp, Roberta L, Witt, Luke, Chen, Xin, Jordan, Justin T, Gilbert, Thomas S K, Stemmer-Rachamimov, Anat, Gusella, James F, Plotkin, Scott R, Haggarty, Stephen J, Chang, Long-Sheng, Johnson, Gary L, Ramesh, Vijaya
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Basic and Translational Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071664/
https://ncbi.nlm.nih.gov/pubmed/29982664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados